|
⚲
|
| Keyboard |
| CAVU Advisors LLC
✚
|
|
|---|---|
| CRD # | 285093 |
| SEC # | 802-112341 |
| CIK # | 0001813310 |
| AUM | |
| Employees | |
| Fees | |
| Minimum | |
| Phone | 203-518-4012 |
| Address | 191 Post Rd West Westport, CT 06880 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($) |
|---|
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001813310] | |
| 4 | [0001813310] |
| Firm Profile (Form ADV) | |
|---|---|
| LEI | 549300KG8WJDGLNJ0F25 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
Actuate Therapeutics Inc ACTU
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2025-06-18 | Grant | 34,000 | $0.00 | |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-13 | Sell | 1,903 | $3.09 | 5,880 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-13 | Sell | 7,206 | $3.09 | 22,267 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-13 | Sell | 14,218 | $3.09 | 43,934 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-13 | Sell | 12,319 | $3.09 | 38,066 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-13 | Sell | 4,354 | $3.09 | 13,454 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-12 | Sell | 18,678 | $3.38 | 63,132 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-12 | Sell | 6,601 | $3.38 | 22,311 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-12 | Sell | 2,886 | $3.38 | 9,755 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-12 | Sell | 21,557 | $3.38 | 72,863 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-12 | Sell | 10,925 | $3.38 | 36,926 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-11 | Sell | 45 | $3.40 | 153 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-11 | Sell | 293 | $3.40 | 996 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-11 | Sell | 103 | $3.40 | 350 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-11 | Sell | 338 | $3.40 | 1,149 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-11 | Sell | 171 | $3.40 | 581 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-10 | Sell | 3 | $3.40 | 10 |
|
Lantern Pharma LTRN
Common Stock
|
2025-06-10 | Sell | 5 | $3.40 | 17 |
| showing 20 of 200 most recent transactions | |||||